• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FARAPULSE, INC. FARAWAVE PULSED FIELD ABLATION CATHETER; CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FARAPULSE, INC. FARAWAVE PULSED FIELD ABLATION CATHETER; CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER Back to Search Results
Device Problem Off-Label Use (1494)
Patient Problems Hemolysis (1886); Renal Failure (2041)
Event Date 03/23/2024
Event Type  Injury  
Manufacturer Narrative
It was indicated that the device was disposed will not be returned for evaluation as the device performed as expected during the procedure and there were no reports of any performance concerns.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
It was reported that following a pulse field ablation (pfa) procedure using a farawave pfa catheter, the patient presented with elevated creatinine levels.During the procedure pulmonary vein ablations were performed using a farawave pfa catheter, additional ablations of the posterior left atrial wall, the mitral isthmus, and the right atrial posterior wall were also performed.Ablations of the posterior left atrial wall, mitral line, and right atrial posterior wall with the farawave pfa catheter are considered off-label use as the catheter's instructions for use indicate the system is intended only for pulmonary vein isolations.Following the procedure, the patient was admitted to the hospital for elevated creatinine levels and given fluid.The patient also had dark urine and laboratory analysis revealed low haptoglobin levels.The clinical picture was consistent with hemolysis resulting in acute renal failure.The patient underwent temporary dialysis, which has since been halted as the patient condition has improved.The catheter was disposed by the facility and will not be returned as the device performed as expected during the procedure and there were no reports of any performance concerns.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FARAWAVE PULSED FIELD ABLATION CATHETER
Type of Device
CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER
Manufacturer (Section D)
FARAPULSE, INC.
3715 haven avenue
suite 110
menlo park CA 94025
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key19145129
MDR Text Key340677332
Report Number2124215-2024-23974
Device Sequence Number1
Product Code QZI
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/19/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient SexMale
-
-